Vaxart, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Vaxart, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2010 to Q3 2024.
  • Vaxart, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $18K, a 53.8% decline year-over-year.
  • Vaxart, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $258K, a 150% increase year-over-year.
  • Vaxart, Inc. annual Income Tax Expense (Benefit) for 2023 was $261K, a 290% increase from 2022.
  • Vaxart, Inc. annual Income Tax Expense (Benefit) for 2022 was $67K, a 37.4% decline from 2021.
  • Vaxart, Inc. annual Income Tax Expense (Benefit) for 2021 was $107K, a 55% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $258K $18K -$21K -53.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $279K $21K +$2K +10.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $277K $45K +$16K +55.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $261K $174K +$158K +988% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $103K $39K +$23K +144% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $80K $19K +$4K +26.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $76K $29K +$9K +45% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $67K $16K -$2K -11.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $69K $16K -$5K -23.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $74K $15K -$15K -50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $89K $20K -$18K -47.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $107K $18K -$15K -45.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $122K $21K -$5K -19.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $127K $30K +$4K +15.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $123K $38K -$115K -75.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $238K $33K -$163K -83.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $401K $26K -$5K -16.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $406K $26K +$13K +100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $393K $153K -$97K -38.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $490K $196K Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $31K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $13K +$12K +1200% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $250K +$222K +793% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q2 2018 $1K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $28K -$172K -86% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $100K $0 0% Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-06
Q1 2017 $200K Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $100K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-06
Q3 2013 $100K -$100K $0 0% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $100K $218K -$1.67M -88.5% Apr 1, 2013 Jun 30, 2013 10-K 2015-09-11
Q1 2013 $1.77M -$12K -$158K -108% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $1.93M -$6K +$514K +98.8% Oct 1, 2012 Dec 31, 2012 10-Q 2013-02-11
Q3 2012 $1.42M -$100K +$1.92M +95% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$500K $1.89M Apr 1, 2012 Jun 30, 2012 10-K 2014-09-30
Q1 2012 $146K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$520K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-11
Q3 2011 -$2.02M -$253K -14.3% Jun 26, 2011 Sep 24, 2011 10-Q 2011-11-02
Q3 2010 -$1.77M Jun 27, 2010 Sep 25, 2010 10-Q 2011-11-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.